Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
Hai-Yan FuYu LuoJian-Peng GaoLin WangHong-Juan LiXiang LiLian XueXiao-Qing TangHai-Wen LiYing-Rong DuPublished in: BioMed research international (2020)
This study found that the use of short-term, low-dose glucocorticoids does not negatively influence the clinical outcome, without affecting the final clearance of viral nucleic acid in mild COVID-19 patients.